InvestorsHub Logo
Followers 468
Posts 26893
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 4

Monday, 05/07/2012 8:07:16 AM

Monday, May 07, 2012 8:07:16 AM

Post# of 12
7:57AM On The Wires (WIRES) : BioSpecifics Technologies (BSTC) has initiated a placebo controlled randomized Phase II clinical trial, Chien-804, to evaluate the efficacy of XIAFLEX for canines with benign subcutaneous lipomas.